Transdermal drug delivery has also shown promising results in insulin delivery for diabetes patients, offering a convenient and effective alternative to traditional insulin injections (Xie et al., 2015; Lee et al., 2017a; Wang et al., 2020; Zhang et al., 2021). This evidence concerns the gene INS and diabetes mellitus.